Helicobacter pylori: Present status and future prospects in Japan

Journal of Gastroenterology

Volumn 42, Issue 1, 2007, Pages 1-15

  Suzuki, Hidekazu ^a   Hibi, Toshifumi ^a   Marshall, Barry James ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Gastric cancer; Gastritis; H. pylori diagnosis; H. pylori eradication; Peptic ulcer

Indexed keywords

AMOXICILLIN; ANTICOAGULANT AGENT; CLARITHROMYCIN; COLLOIDAL BISMUTH COMPOUND; LEVOFLOXACIN; LITHIUM; METRONIDAZOLE; OMEPRAZOLE; PHENYTOIN; PLACEBO; TINIDAZOLE;

ABDOMINAL PAIN; BACTERIUM ISOLATION; CANCER INCIDENCE; CLINICAL TRIAL; DIARRHEA; DISEASE CONTROL; DRUG ERUPTION; DYSGEUSIA; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE SYSTEM; JAPAN; NAUSEA; NONHUMAN; PATHOPHYSIOLOGY; PEPTIC ULCER; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; SEIZURE; STOMACH CANCER; VOMITING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTRIC MUCOSA; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; PEPTIC ULCER; STEM CELLS; STOMACH NEOPLASMS;

EID: 33847660516     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-006-1990-z     Document Type: Review

References (184)

1. N Uemura S Okamoto S Yamamoto N Matsumura S Yamaguchi M Yamakido 2001 Helicobacter pylori infection and the development of gastric cancer N Engl J Med 345 784-9 11556297 1:STN:280:DC%2BD3MrgslCqtA%3D%3D 10.1056/ NEJMoa001999
2. P Correa 2003 Bacterial infections as a cause of cancer J Natl Cancer Inst 95 E312671026
3. MJ Blaser JC Atherton 2004 Helicobacter pylori persistence: Biology and disease J Clin Invest 113 321-33 14755326 1:CAS:528:DC%2BD2cXhtFSlsr0%3D 10.1172/JCI200420925
4. J Parsonnet D Forman 2004 Helicobacter pylori infection and gastric cancer - for want of more outcomes JAMA 291 244-5 14722152 1:CAS:528:DC%2BD2cXkvVCltg%3D%3D 10.1001/jama.291.2.244
5. H Suzuki S Miura M Suzuki S Terada M Nakamura M Tsuchiya 1994 Gastric mucosal injury: Microcirculation and Helicobacter pylori Keio J Med 43 1-8 8189675 1:STN:280:ByuB2cnptVw%3D
6. H Suzuki T Masaoka S Nomura Y Hoshino K Kurabayashi Y Minegishi 2003 Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease Keio J Med 52 163-73 14529149
7. A Gasbarrini F Franceschi R Tartaglione R Landolfi P Pola G Gasbarrini 1998 Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori Lancet 352 8789742983 1:STN:280:DyaK1cvhtl2itw%3D%3D 10.1016/S0140-6736(05)60004-9
8. A Barabino C Dufour CE Marino F Claudiani A De Alessandri 1999 Unexplained refractory iron-deficiency anemia associated with Helicobacter pylori gastric infection in children: Further clinical evidence J Pediatr Gastroenterol Nutr 28 116-9 9890483 1:STN:280:DyaK1M7gsFCruw%3D%3D 10.1097/00005176-199901000-00027
9. J Kountouras G Deretzi C Zavos P Karatzoglou L Touloumis T Nicolaides 2005 Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy Eur J Neurol 12 139-43 15679702 1:STN:280:DC%2BD2M%2Flt1Kmuw%3D%3D 10.1111/ j.1468-1331.2004.00977.x
10. V Pasceri G Patti G Cammarota C Pristipino G Richichi G Di Sciascio 2006 Virulent strains of Helicobacter pylori and vascular diseases: A meta-analysis Am Heart J 151 1215-22 16781222 1:CAS:528:DC%2BD28XlsFOis7Y%3D 10.1016/j.ahj.2005.06.041
11. J Kountouras M Tsolaki E Gavalas M Boziki C Zavos P Karatzoglou 2006 Relationship between Helicobacter pylori infection and Alzheimer disease Neurology 66 938-40 16567719 1:STN:280:DC%2BD287nsVCjsg%3D%3D 10.1212/ 01.wnl.0000203644.68059.5f
12. A Asahi M Kuwana H Suzuki T Hibi Y Kawakami Y Ikeda 2006 Effects of a Helicobacter pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura Haematologica 91 1436-7 16963398 1:CAS:528:DC%2BD28XhtF2gsrzE 1436-7
13. BJ Marshall JA Armstrong DB McGechie RJ Glancy 1985 Attempt to fulfil Koch's postulates for pyloric Campylobacter Med J Aust 142 436-9 3982345 1:STN:280:BiqC28zhsVM%3D
14. H Kavermann BP Burns K Angermuller S Odenbreit W Fischer K Melchers 2003 Identification and characterization of Helicobacter pylori genes essential for gastric colonization J Exp Med 197 813-22 12668646 1:CAS:528:DC%2BD3sXivFaisLs%3D 10.1084/jem.20021531
15. BP Guo JJ Mekalanos 2002 Rapid genetic analysis of Helicobacter pylori gastric mucosal colonization in suckling mice Proc Natl Acad Sci U S A 99 8354-9 12060779 1:CAS:528:DC%2BD38XkvVGgu7g%3D 10.1073/pnas.122244899
16. S Suerbaum P Michetti 2002 Helicobacter pylori infection N Engl J Med 347 1175-86 12374879 1:CAS:528:DC%2BD38XnslShsbo%3D 10.1056/NEJMra020542
17. BJ Marshall JR Warren 1984 Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration Lancet 1 1311-5 6145023 1:STN:280:BiuB3Mfjt1E%3D 10.1016/S0140-6736(84)91816-6
18. ED Palmer 1954 Investigation of the gastric mucosal spirochetes of the human Gastroenterology 27 218-20 13183283 1:STN:280:CyuC3czksFI%3D
19. G Bizzozero 1893 Ueber die schlauchformigen Dursen des Magen-darmkanals und die Beziehungen ihres Epithels zu dem Oberflachenepithel der Schleimhaut Arch Mikr Anat 42 82-152
20. K Kasai R Kobayashi 1919 The stomach spirochete occurring in mammals J Parasitol 6 1-10 10.2307/3271009
21. K Saito 2002 Introductory remark of Dr. Rokuzo Kobayashi's achievements Keio J Med 51 2-3 12528927
22. BJ Marshall 2002 Gastric spirochaetes: 100 years of discovery before and after Kobayashi Keio J Med 51 33-7 12528934
23. DY Graham HM Malaty DG Evans DJ Evans Jr PD Klein E Adam 1991 Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status Gastroenterology 100 1495-501 2019355 1:STN:280:By6B3cbntVw%3D
24. J Parsonnet 1995 The incidence of Helicobacter pylori infection Aliment Pharmacol Ther 9 Suppl 2 45-51 8547528
25. RW Frenck Jr J Clemens 2003 Helicobacter in the developing world Microbes Infect 5 705-13 12814771 10.1016/S1286-4579(03)00112-6
26. LE Hansson O Nyren AW Hsing R Bergstrom S Josefsson WH Chow 1996 The risk of stomach cancer in patients with gastric or duodenal ulcer disease N Engl J Med 335 242-9 8657240 1:STN:280:BymB28njvVI%3D 10.1056/ NEJM199607253350404
27. E Zucca F Bertoni E Roggero G Bosshard G Cazzaniga E Pedrinis 1998 Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach N Engl J Med 338 804-10 9504941 1:STN:280:DyaK1c7lvVSgtw%3D%3D 10.1056/NEJM199803193381205
28. W Fischbach B Dragosics ME Kolve-Goebeler C Ohmann A Greiner Q Yang 2000 Primary gastric B-cell lymphoma: Results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group Gastroenterology 119 1191-202 11054376 1:STN:280:DC%2BD3M%2Fkt1yltA%3D%3D 10.1053/gast.2000.19579
29. AM Ekstrom M Held LE Hansson L Engstrand O Nyren 2001 Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection Gastroenterology 121 784-91 11606491 1:STN:280:DC%2BD3MrlvFKmtQ%3D%3D 10.1053/gast.2001.27999
30. M Naumann JE Crabtree 2004 Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis Trends Microbiol 12 29-36 14700549 1:CAS:528:DC%2BD3sXhtVWjtLnK 10.1016/j.tim.2003.11.005
31. H Suzuki M Mori AA Sakaguchi M Suzuki S Miura H Ishii 1998 Enhanced levels of C-X-C chemokine, human GROα, in H. pylori-associated gastric disease J Gastroenterol Hepatol 13 516-20 9641651 1:CAS:528:DyaK1cXktVCjt7k%3D
32. M Karita MK Tummuru HP Wirth MJ Blaser 1996 Effect of growth phase and acid shock on Helicobacter pylori cagA expression Infect Immun 64 4501-7 8890198 1:CAS:528:DyaK28XmsVWnsbc%3D
33. JE Crabtree JI Wyatt GM Sobala G Miller DS Tompkins JN Primrose 1993 Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer Gut 34 1339-43 8244098 1:STN:280:ByuD28zlvVc%3D
34. D Basso F Navaglia L Brigato MG Piva A Toma E Greco 1998 Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases Gut 43 182-6 10189841 1:STN:280:DyaK1M3gsFyguw%3D%3D
35. JC Atherton P Cao RM Peek Jr MK Tummuru MJ Blaser TL Cover 1995 Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration J Biol Chem 270 17771-7 7629077 1:CAS:528:DyaK2MXnt1Crt7Y%3D 10.1074/jbc.270.30.17771
36. W Fischer J Puls R Buhrdorf B Gebert S Odenbreit R Haas 2001 Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8 Mol Microbiol 42 1337-48 11886563 1:CAS:528:DC%2BD3MXptFOiu70%3D 10.1046/j.1365-2958.2001.02714.x
37. M Stein R Rappuoli A Covacci 2000 Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation Proc Natl Acad Sci U S A 97 1263-8 10655519 1:CAS:528:DC%2BD3cXpvFeksg%3D%3D 10.1073/pnas.97.3.1263
38. H Higashi R Tsutsumi S Muto T Sugiyama T Azuma M Asaka 2002 SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein Science 295 683-6 11743164 1:CAS:528:DC%2BD38XptF2rsQ%3D%3D 10.1126/science.1067147
39. M Selbach S Moese CR Hauck TF Meyer S Backert 2002 Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo J Biol Chem 277 6775-8 11788577 1:CAS:528:DC%2BD38XitV2mtrg%3D 10.1074/jbc.C100754200
40. J Tanaka T Suzuki H Mimuro C Sasakawa 2003 Structural definition on the surface of Helicobacter pylori type IV secretion apparatus Cell Microbiol 5 395-404 12780777 1:CAS:528:DC%2BD3sXkvVeku7Y%3D 10.1046/ j.1462-5822.2003.00286.x
41. R Tsutsumi H Higashi M Higuchi M Okada M Hatakeyama 2003 Attenuation of Helicobacter pylori CagA × SHP-2 signaling by interaction between CagA and C-terminal Src kinase J Biol Chem 278 3664-70 12446738 1:CAS:528:DC%2BD3sXot1Krsw%3D%3D 10.1074/jbc.M208155200
42. H Higashi R Tsutsumi A Fujita S Yamazaki M Asaka T Azuma 2002 Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites Proc Natl Acad Sci U S A 99 14428-33 12391297 1:CAS:528:DC%2BD38XosF2hsrk%3D 10.1073/ pnas.222375399
43. H Higashi A Nakaya R Tsutsumi K Yokoyama Y Fujii S Ishikawa 2004 Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation J Biol Chem 279 17205-16 14963045 1:CAS:528:DC%2BD2cXjt1Ggu74%3D 10.1074/jbc.M309964200
44. UEH Mai GI Prez-Perez JB Allen SM Wahl MJ Blaser PD Smith 1992 Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa J Exp Med 175 517-25 1732414 1:CAS:528:DyaK38XotFyktw%3D%3D 10.1084/jem.175.2.517
45. PM Craig MC Territo WE Karnes JH Walsh 1992 Helicobacter pylori secretes a chemotactic factor monocytes and neutrophils Gut 33 1020-3 1398224 1:STN:280:ByyD3Mzhtl0%3D
46. M Suzuki S Miura M Suematsu D Fukumura I Kurose H Suzuki 1992 Helicobacter pylori-ssociated ammonia production enhances neutrophil-dependent gastric mucosal cell injury Am J Physiol 263 G719-25 1443147 1:CAS:528:DyaK3sXpvFaqsw%3D%3D
47. MB Grisham MM Jefferson DF Melton EL Thomas 1984 Chlorination of endogenous amines by isolated neutrophils: Ammonia-dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines J Biol Chem 259 10404-13 6381484 1:CAS:528:DyaL2cXlt1yksb8%3D
48. B Halliwell OI Aruoma 1991 DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems FEBS Lett 281 9-19 1849843 1:CAS:528:DyaK3MXisVaisbo%3D 10.1016/0014-5793(91)80347-6
49. F Farinati R Cardin VM Russo G Busatto M Franco M Rugge 2003 Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: A potential pathway to cancer? Helicobacter 8 227-34 12752735 10.1046/j.1523-5378.2003.00149.x 2003
50. H Suzuki M Mori K Seto A Kai C Kawaguchi M Suzuki 1999 H. pylori-associated gastric pro- and anti-oxidant formation in Mongolian gerbils Free Radic Biol Med 26 679-84 10218657 1:CAS:528:DyaK1MXitVKisbc%3D 10.1016/S0891-5849(98)00248-2
51. H Suzuki M Mori K Seto S Nagahashi C Kawaguchi A Kai 1999 Ethanol intake preceding Helicobacter pylori inoculation promotes gastric mucosal inflammation in Mongolian gerbils J Gastroenterol Hepatol 14 1062-9 10574132 1:CAS:528:DC%2BD3cXmsVCltw%3D%3D 10.1046/ j.1440-1746.1999.01999.x
52. H Suzuki T Masaoka H Hosoda T Ota Y Minegishi S Nomura 2004 Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils Gut 53 187-94 14724148 1:CAS:528:DC%2BD2cXhs1Ght70%3D 10.1136/gut.2003.021568
53. H Suzuki Y Minegishi Y Nomoto T Ota T Masaoka GR van den Brink 2005 Down-regulation of a morphogen (sonic hedgehog) gradient in the gastric epithelium of Helicobacter pylori - infected Mongolian gerbils J Pathol 206 186-97 15818572 1:CAS:528:DC%2BD2MXlsFejtbc%3D 10.1002/path.1763
54. K Ogura S Maeda M Nakao T Watanabe M Tada T Kyutoku 2000 Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil J Exp Med 192 1601-10 11104802 1:CAS:528:DC%2BD3cXosF2ntrk%3D 10.1084/jem.192.11.1601
55. DA Israel N Salama CN Arnold SF Moss T Ando HP Wirth 2001 Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses J Clin Invest 107 611-20 11238562 1:CAS:528:DC%2BD3MXhs12nsL4%3D
56. H Suzuki T Masaoka H Hosoda S Nomura T Ohara K Kangawa 2004 Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio - a possible novel and non-invasive marker for gastric atrophy Hepatogastroenterology 51 1249-54 15362725 1:CAS:528:DC%2BD2cXmvVGiu78%3D
57. Nishizawa T, Suzuki H, Masaoka T, Minegishi Y, Iwasaki E, Hibi T. Helicobacter pylori eradication restored sonic hedgehog expression in the human stomach. Hepatogastroenterology 2007 (in press)
58. RMJ Peek SF Moss KT Tham GI Perez-Perez S Wang GG Miller 1997 Helicobacter pylori CagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis J Natl Cancer Inst 89 863-8 9196252 1:CAS:528:DyaK2sXksVWqur0%3D 10.1093/jnci/89.12.863
59. H Suzuki M Miyazawa S Nagahashi K Seto A Kai M Suzuki 2002 Attenuated apoptosis in H. pylori-colonized gastric mucosa of Mongolian gerbils in comparison with mice Dig Dis Sci 47 90-9 11837740 10.1023/A:1013219621422
60. T Watanabe M Tada H Nagai S Sasaki M Nakao 1998 Helicobacter pylori infection induces gastric cancer in Mongolian gerbils Gastroenterology 115 642-8 9721161 1:STN:280:DyaK1czoslynsA%3D%3D 10.1016/ S0016-5085(98)70143-X
61. S Honda T Fujioka M Tokieda R Satoh A Nishizono M Nasu 1998 Development of Helicobacter pylori - induced gastric carcinoma in Mongolian gerbils Cancer Res 58 4255-9 9766647 1:CAS:528:DyaK1cXmsVyqs7Y%3D
62. BJ Marshall DB McGechie PA Rogers RJ Glancy 1985 Pyloric Campylobacter infection and gastroduodenal disease Med J Aust 142 439-44 3982346 1:STN:280:BiqC28zhsVw%3D
63. A Nomura GN Stemmermann PH Chyou GI Perez-Perez MJ Blaser 1994 Helicobacter pylori infection and the risk for duodenal and gastric ulceration Ann Intern Med 120 977-81 7741826 1:STN:280:ByuB2c7kvFM%3D
64. EA Rauws GN Tytgat 1990 Cure of duodenal ulcer associated with eradication of Helicobacter pylori Lancet 335 1233-5 1971318 1:STN:280:By%2BB2MflsVU%3D 10.1016/0140-6736(90)91301-P
65. E Hentschel G Brandstatter B Dragosics AM Hirschl H Nemec K Schutze 1993 Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer N Engl J Med 328 308-12 8419816 1:STN:280:ByyC38rmt1E%3D 10.1056/ NEJM199302043280503
66. BJ Marshall CS Goodwin JR Warren R Murray ED Blincow SJ Blackbourn 1988 Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori Lancet 2 1437-42 2904568 1:STN:280:BiaD2s%2FgtF0%3D 10.1016/S0140-6736(88)90929-4
67. JG Penston 1994 Review article: Helicobacter pylori eradication - understandable caution but no excuse for inertia Aliment Pharmacol Ther 8 369-89 7986962 1:STN:280:ByqD2sfktV0%3D
68. GN Tytgat 1995 Peptic ulcer and Helicobacter pylori: Eradication and relapse Scand J Gastroenterol Suppl 210 70-2 8578212 1:STN:280:BymC3MjovVw%3D
69. RJ Hopkins LS Girardi EA Turney 1996 Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review Gastroenterology 110 1244-52 8613015 1:STN:280:BymC1czhs1c%3D 10.1053/gast.1996.v110.pm8613015
70. L Laine RJ Hopkins LS Girardi 1998 Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials Am J Gastroenterol 93 1409-15 9732917 1:STN:280:DyaK1cvgtFOmsQ%3D%3D
71. AT Axon CA O'Morain KD Bardhan JP Crowe AD Beattie RP Thompson 1997 Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection BMJ 314 565-8 9055715 1:STN:280:ByiB3cfnslc%3D
72. Y Fukuda I Yamamoto M Okui Y Tonokatsu K Tamura T Shimoyama 1995 Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori Eur J Gastroenterol Hepatol 7 Suppl 1 S45-7 8574735
73. M Kato M Asaka M Kudo M Sukegawa M Katagiri T Koshiyama 1996 Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients Aliment Pharmacol Ther 10 821-7 8899093 1:CAS:528:DyaK28Xmslajsrs%3D 10.1046/ j.1365-2036.1996.52194000.x
74. M Lazzaroni M Perego S Bargiggia G Maconi R Fiocca E Solcia 1997 Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: A two-year, double-blind, placebo controlled study Ital J Gastroenterol Hepatol 29 220-7 9646213 1:CAS:528:DyaK1cXnsVSiu7g%3D
75. K Seppala P Pikkarainen P Sipponen E Kivilaakso MH Gormsen 1995 Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Finnish Gastric Ulcer Study Group Gut 36 834-7 7615269 1:STN:280:ByqA2c%2FhvVU%3D
76. JJ Sung SC Chung TK Ling MY Yung VK Leung EK Ng 1995 Antibacterial treatment of gastric ulcers associated with Helicobacter pylori N Engl J Med 332 139-42 7800005 1:STN:280:ByqD1MfgvVw%3D 10.1056/ NEJM199501193320302
77. Ford AC, Delaney BC, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev 2006 Apr 19;(2):CD003840
78. EJ Kuipers AS Pena G van Kamp AM Uyterlinde G Pals NF Pels 1993 Seroconversion for Helicobacter pylori Lancet 342 328-31 8101585 1:STN:280:ByyA38bptlA%3D 10.1016/0140-6736(93)91473-Y
79. R Roosendaal EJ Kuipers J Buitenwerf C van Uffelen SG Meuwissen GJ Van Kamp 1997 Helicobacter pylori and the birth cohort effect: Evidence of a continuous decrease of infection rates in childhood Am J Gastroenterol 92 1480-2 9317067 1:STN:280:ByiH287jvVI%3D
80. JQ Huang S Sridhar RH Hunt 2002 Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: A meta-analysis Lancet 359 14-22 11809181 1:CAS:528:DC%2BD38XmsV2msQ%3D%3D 10.1016/S0140-6736(02)07273-2
81. FK Chan KF To JC Wu MY Yung WK Leung T Kwok 2002 Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: A randomised trial Lancet 359 9-13 11809180 1:CAS:528:DC%2BD38XmsV2msA%3D%3D 10.1016/S0140-6736(02)07272-0
82. FK Chan SC Chung BY Suen YT Lee WK Leung VK Leung 2001 Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen N Engl J Med 344 967-73 11274623 1:STN:280:DC%2BD3M7pvVKitw%3D%3D 10.1056/ NEJM200103293441304
83. CJ Hawkey Z Tulassay L Szczepanski CJ van Rensburg A Filipowicz-Sosnowska A Lanas 1998 Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention Lancet 352 1016-21 9759744 1:STN:280:DyaK1cvjtVGntg%3D%3D 10.1016/S0140-6736(98)04206-8
84. DA Drossman 2006 The functional gastrointestinal disorders and the Rome III process Gastroenterology 130 1377-90 16678553 10.1053/ j.gastro.2006.03.008
85. J Tack NJ Talley M Camilleri G Holtmann P Hu JR Malagelada 2006 Functional gastroduodenal disorders Gastroen terology 130 1466-79
86. H Suzuki T Nishizawa T Hibi 2006 Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification J Gastroenterol 41 513-23 16868798 10.1007/s00535-006-1847-5
87. NJ Talley RH Hunt 1997 What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms Gastroenterology 113 S67-77 9394764 1:STN:280:DyaK1c%2Fls1OntA%3D%3D 10.1016/S0016-5085(97)70081-7
88. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005 Jan 25;(1):CD002096
89. N Chiba SJ Van Zanten P Sinclair RA Ferguson S Escobedo E Grace 2002 Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: The Canadian adult dyspepsia empiric treatment - Helicobacter pylori positive (CADET-Hp) randomised controlled trial BMJ 324 1012-6 11976244 1:CAS:528:DC%2BD38Xkt1aks7s%3D 10.1136/ bmj.324.7344.1012
90. N Chiba SJ Veldhuyzen Van Zanten S Escobedo E Grace J Lee P Sinclair 2004 Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia Aliment Pharmacol Ther 19 349-58 14984382 1:STN:280:DC%2BD2c%2Fps1Gitw%3D%3D 10.1111/ j.1365-2036.2004.01865.x
91. A Sonnenberg WF Townsend 1995 Costs of duodenal ulcer therapy with antibiotics Arch Intern Med 155 922-8 7726700 1:STN:280:ByqB2cznvV0%3D 10.1001/archinte.155.9.922
92. Delaney B, Ford AC, Forman D, Moayyedi P, Qume M. Initial management strategies for dyspepsia. Cochrane Database Syst Rev 2005 Oct 19;(4):CD001961
93. AC Ford M Qume P Moayyedi NL Arents AT Lassen RF Logan 2005 Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis Gastroenterology 128 1838-44 15940619 10.1053/j.gastro.2005.03.004
94. P Correa C Cuello E Duque 1976 Gastric cancer in Colombia. III. Natural history of precursor lesions J Natl Cancer Inst 57 1027-35 1003539 1:STN:280:CSiD2svjtFI%3D
95. EJ Kuipers AM Uyterlinde AS Pena R Roosendaal G Pals GF Nelis 1995 Long-term sequelae of Helicobacter pylori gastritis Lancet 345 1525-8 7791437 1:STN:280:ByqA3M7lsVE%3D 10.1016/S0140-6736(95)91084-0
96. H Suzuki T Hibi 2006 Oxidative stress in Helicobacter pylori-associated gastroduodenal disease J Clin Biochem Nutr 39 56-63 1:CAS:528:DC%2BD28XhtVKitrrE 10.3164/jcbn.39.56
97. EM El-Omar M Carrington WH Chow KE McColl JH Bream HA Young 2000 Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 404 398-402 10746728 1:CAS:528:DC%2BD3cXitlyltb4%3D 10.1038/35006081
98. A Uehara T Okumura C Sekiya K Okamura Y Takasugi M Namiki 1989 Interleukin-1 inhibits the secretion of gastric acid in rats: Possible involvement of prostaglandin Biochem Biophys Res Commun 162 1578-84 2788416 1:CAS:528:DyaL1MXltlaht7k%3D 10.1016/0006-291X(89)90855-3
99. IR Hwang T Kodama S Kikuchi K Sakai LE Peterson DY Graham 2002 Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection Gastroenterology 123 1793-803 12454835 1:CAS:528:DC%2BD38Xps1yktb4%3D 10.1053/gast.2002.37043
100. C Figueiredo JC Machado P Pharoah R Seruca S Sousa R Carvalho 2002 Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma J Natl Cancer Inst 94 1680-7 12441323 1:CAS:528:DC%2BD38Xpslequrw%3D
101. R Rad C Prinz B Neu M Neuhofer M Zeitner P Voland 2003 Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa J Infect Dis 188 272-81 12854083 1:CAS:528:DC%2BD3sXmslShtb0%3D 10.1086/376458
102. JC Machado C Figueiredo P Canedo P Pharoah R Carvalho S Nabais 2003 A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma Gastroenterology 125 364-71 12891537 1:CAS:528:DC%2BD3sXmvFygu70%3D 10.1016/S0016-5085(03)00899-0
103. P Sipponen M Kekki J Haapakoski T Ihamaki M Siurala 2985 Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross-sectional data Int J Cancer 35 173-7 10.1002/ijc.2910350206
104. EJ Kuipers 1998 Review article: Relationship between Helicobacter pylori, atrophic gastritis and gastric cancer Aliment Pharmacol Ther 12 Suppl 1 25-36 9701002 10.1111/j.1365-2036.1998.00009.x
105. D Forman F Sitas DG Newell AR Stacey J Boreham R Peto 1990 Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China Int J Cancer 46 608-11 2210881 1:STN:280:By6D3cjpvVY%3D 10.1002/ijc.2910460410
106. The EUROGAST Study Group 1993 An international association between Helicobacter pylori infection and gastric cancer Lancet 341 1359-62 10.1016/0140-6736(93)90938-D
107. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans 1994 Schistosomes, liver flukes and Helicobacter pylori IARC Monogr Eval Carcinog Risks Hum 61 177-240
108. A Ekstrom M Held L Hansson L Engstrand O Nyren 2001 Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection Gastroenterology 121 784-91 11606491 1:STN:280:DC%2BD3MrlvFKmtQ%3D%3D 10.1053/gast.2001.27999
109. G Rieder JL Merchant R Haas 2005 Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils Gastroenterology 128 1229-42 15887107 1:CAS:528:DC%2BD2MXlt1Cisrg%3D 10.1053/j.gastro.2005.02.064
110. EJ Kuipers GI Perez-Perez SG Meuwissen MJ Blaser 1995 Helicobacter pylori and atrophic gastritis: Importance of the cagA status J Natl Cancer Inst 87 1777-80 7473834 1:STN:280:BymD2sjgsl0%3D 10.1093/jnci/ 87.23.1777
111. J Parsonnet GD Friedman N Orentreich H Vogelman 1997 Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection Gut 40 297-301 9135515 1:STN:280:ByiB1c7itVM%3D
112. DM Parkin 2001 Global cancer statistics in the year 2000 Lancet Oncol 2 533-43 11905707 1:STN:280:DC%2BD387ntlCrtw%3D%3D 10.1016/ S1470-2045(01)00486-7
113. EJ Kuipers GF Nelis EC Klinkenberg-Knol P Snel D Goldfain JJ Kolkman 2004 Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: Results of a randomised controlled trial Gut 53 12-20 14684569 1:CAS:528:DC%2BD2cXptlKrtA%3D%3D 10.1136/gut.53.1.12
114. WK Leung SR Lin JY Ching KF To EK Ng FK Chan 2004 Factors predicting progression of gastric intestinal metaplasia: Results of a randomised trial on Helicobacter pylori eradication Gut 53 1244-9 15306578 1:STN:280:DC%2BD2cvgt1Cmuw%3D%3D 10.1136/gut.2003.034629
115. C Ley A Mohar J Guarner R Herrera-Goepfert LS Figueroa D Halperin 2004 Helicobacter pylori eradication and gastric preneoplastic conditions: A randomized, double-blind, placebo-controlled trial Cancer Epidemiol Biomarkers Prev 13 4-10 14744726 1:CAS:528:DC%2BD2cXmsVWgtQ%3D%3D 10.1158/1055-9965.EPI-03-0124
116. R Mera ET Fontham LE Bravo JC Bravo MB Piazuelo MC Camargo 2004 Long term follow up of patients treated for Helicobacter pylori infection Gut 54 1536-40 10.1136/gut.2005.072009
117. BE Schenk EJ Kuipers GF Nelis E Bloemena JC Thijs P Snel 2000 Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy Gut 46 615-21 10764703 1:CAS:528:DC%2BD3cXjsVShu7s%3D 10.1136/ gut.46.5.615
118. BC Wong SK Lam WM Wong JS Chen TT Zheng RE Feng 2004 Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: A randomized controlled trial JAMA 291 187-94 14722144 1:CAS:528:DC%2BD2cXkvVCjuw%3D%3D 10.1001/jama.291.2.187
119. S Take M Mizuno K Ishiki Y Nagahara T Yoshida K Yokota 2005 The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease Am J Gastroenterol 100 1037-42 15842576 10.1111/j.1572-0241.2005.41384.x
120. H Yatsuya H Toyoshima A Tamakoshi S Kikuchi K Tamakoshi T Kondo 2004 Individual and joint impact of family history and Helicobacter pylori infection on the risk of stomach cancer: A nested case-control study Br J Cancer 91 929-34 15280918 1:STN:280:DC%2BD2cvitF2rsA%3D%3D
121. S Sasazuki M Inoue M Iwasaki T Otani S Yamamoto S Ikeda 2006 Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: A nested case-control study Cancer Epidemiol Biomarkers Prev 15 1341-7 16835334 1:CAS:528:DC%2BD28XmslSgtLw%3D 10.1158/1055-9965.EPI-05-0901
122. S Eidt M Stolte R Fischer 1994 Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas J Clin Pathol 47 436-9 8027397 1:STN:280:ByuB1MbovVI%3D
123. J Parsonnet S Hansen L Rodriguez AB Gelb RA Warnke E Jellum 1994 Helicobacter pylori infection and gastric lymphoma N Engl J Med 330 1267-71 8145781 1:STN:280:ByuC1MrjsVA%3D 10.1056/NEJM199405053301803
124. J Parsonnet PG Isaacson 2004 Bacterial infection and MALT lymphoma N Engl J Med 350 213-5 14724298 1:CAS:528:DC%2BD2cXkvVKhsw%3D%3D 10.1056/ NEJMp038200
125. A de Mascarel A Ruskone-Fourmestraux A Lavergne-Slove F Megraud P Dubus JP Merlio 2005 Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue Virchows Arch 446 219-24 15742170 10.1007/ s00428-005-1217-3 1:CAS:528:DC%2BD2MXis1OkurY%3D
126. W Fischbach ME Goebeler-Kolve B Dragosics A Greiner M Stolte 2004 Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: Experience from a large prospective series Gut 53 34-7 14684573 1:STN:280:DC%2BD2c%2FhtlegtQ%3D%3D 10.1136/gut.53.1.34
127. S Nakamura T Matsumoto H Suekane H Matsumoto M Esaki T Yao 2005 Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment Cancer 104 532-40 15937928 10.1002/cncr.21152
128. T Wundisch C Thiede A Morgner A Dempfle A Gunther H Liu 2005 Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication J Clin Oncol 23 8018-24 16204012 10.1200/JCO.2005.02.3903
129. M Raderer B Streubel S Woehrer A Puespoek U Jaeger M Formanek 2005 High relapse rate in patients with MALT lymphoma warrants lifelong follow-up Clin Cancer Res 11 3349-52 15867234 10.1158/1078-0432.CCR-04-2282
130. H Inagaki T Nakamura C Li T Sugiyama M Asaka J Kodaira 2004 Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter Pylori eradication and detection of API2-MALT1 fusion Am J Surg Pathol 28 1560-7 15577674 10.1097/00000478-200412000-00003
131. H Liu H Ye A Ruskone-Fourmestraux D De Jong S Pileri C Thiede 2002 T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication Gastroenterology 122 1286-94 11984515 1:CAS:528:DC%2BD38Xkt1CrurY%3D 10.1053/gast.2002.33047
132. BF Werdmuller RJ Loffeld 1997 Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis Dig Dis Sci 42 103-5 9009123 1:STN:280:ByiC283htlI%3D 10.1023/A:1018841222856
133. CA Fallone AN Barkun MU Gottke LM Best VG Loo S Veldhuyzen van Zanten 2000 Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases Am J Gastroenterol 95 659-69 10710054 1:STN:280:DC%2BD3c7ntlarug%3D%3D 10.1111/j.1572-0241.2000.01970.x
134. J Labenz AL Blum E Bayerdorffer 1997 Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis Gastroenterology 112 1442-7 9136820 1:STN:280:ByiB1c3ltFU%3D 10.1016/ S0016-5085(97)70024-6
135. N Vakil B Hahn D McSorley 2000 Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection Aliment Pharmacol Ther 14 45-51 10632644 1:STN:280:DC%2BD3c%2FpvVegtw%3D%3D 10.1046/j.1365-2036.2000.00677.x
136. W Schwizer M Thumshirn J Dent I Guldenschuh D Menne G Cathomas 2001 Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: A randomised controlled trial Lancet 357 1738-42 11403809
137. H Suzuki T Masaoka S Nomura Y Hoshino K Kurabayashi Y Minegishi 2003 Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease Keio J Med 52 163-73 14529149
138. JR Warren BJ Marshall 1983 Unidentified curved bacilli on gastric epithelium in active chronic gastritis Lancet 1 8336 1273-5
139. BJ Marshall JR Warren GJ Francis SR Langton CS Goodwin B Chir 1987 Rapid urease test in the management of Campylobacter pyloridis-associated gastritis Am J Gastroenterol 82 200-10 3548326 1:STN:280:BiiC2MzivVM%3D
140. PD Klein HM Malaty RF Martin KS Graham RM Genta DY Graham 1996 Noninvasive detection of Helicobacter pylori infection in clinical practice: The 13C urea breath test Am J Gastroenterol 91 690-4 8677930 1:STN:280:BymC1cnmsVY%3D
141. C Wesjnen H Hendriks A Hoes W Verweij T Verheij N de Wit 2001 New immunoassay for the detection of Helicobacter pylori infection compared with urease test, 13C test and histology: Validation in the primary care setting J Microbiol Methods 46 235-40 10.1016/S0167-7012(01)00275-5
142. D Narinesingh T Ngo 2002 Immunochromatographic flow-injection method for detection of human serum immunoglobulin G antibodies to Helicobacter pylori Ann Chim Acta 453 53-61 1:CAS:528:DC%2BD38XptlCgtg%3D%3D 10.1016/ S0003-2670(01)01486-6
143. N Fujioka M Fahey G Hamada I Nishimoto L Kowalski K Iriya 2001 Serological Immunoglobulin G antibody titers to Helicobacter pylori in Japanese Brazilian and Non-Japanese Brazilian gastric cancer patients and controls in Sao Paulo Jpn J Cancer Res 92 829-35 11509113 1:CAS:528:DC%2BD3MXnsFSht7c%3D
144. D Wu C Kuo C Lu Y Su F Yu Y Lee 2001 Evaluation of an office-based urine test for detecting Helicobacter pylori: A prospective pilot study Hepatogastroenterology 48 614-7 11462887 1:STN:280:DC%2BD38%2FitFOnsQ%3D%3D
145. D Graham S Reddy 2001 Rapid detection of anti-Helicobacter pylori IgG in urine using immunochromatography Aliment Pharmacol Ther 15 699-702 11328264 1:CAS:528:DC%2BD3MXjslCjsb4%3D 10.1046/j.1365-2036.2001.00968.x
146. G Manes A Balzano G Iaquinto C Ricci M Piccirillo N Giardullo 2001 Accuracy of stool antigen test in posteradication assessment of Helicobacter pylori infection Dig Dis Sci 46 2440-4 11713949 1:STN:280:DC%2BD3MnmvVGksg%3D%3D 10.1023/A:1012319718848
147. A Leodolter K Agha-Amiri U Peitz C Gerards M Ebert P Malfertheiner 2001 Validity of a Helicobacter pylori stool antigen assay for the assessment of H. pylori status following eradication therapy Eur J Gastroenterol Hepatol 13 673-6 11434593 1:STN:280:DC%2BD38%2Fhs1WksA%3D%3D 10.1097/ 00042737-200106000-00010
148. D Vaira N Vakil M Menegatti B van't Hoff C Ricci L Gatta 2002 The stool antigen test for detection of Helicobacter pylori after eradication therapy Ann Intern Med 136 280-7 11848725 1:CAS:528:DC%2BD38XhvF2ktL0%3D
149. J Gisbert J Pajares 2001 Diagnosis of Helicobacter pylori infection by stool antigen determination: A systematic review Am J Gastroenterol 96 2829-38 11693315 1:STN:280:DC%2BD3MnjvVWktA%3D%3D 10.1111/ j.1572-0241.2001.04235.x
150. T Lind S Veldhuyzen van Zanten P Unge R Spiller E Bayerdorffer C O'Morain 1996 Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH I Study Helicobacter 1 138-44 9398894 1:STN:280:DyaK1c%2FmtFWnsA%3D%3D
151. T Matsuhisa T Kawai T Masaoka H Suzuki M Ito Y Kawamura 2006 Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori infection in the Japanese population: A multicenter study in the Tokyo Metropolitan Area Helicobacter 11 152-8 16684262 1:CAS:528:DC%2BD28XmtFamtLc%3D 10.1111/j.1523-5378.2006.00394.x
152. JP Gisbert M Castro-Fernandez F Bermejo A Perez-Aisa J Ducons M Fernandez-Bermejo 2006 Third-line rescue therapy with levofloxacin after two H. pylori treatment failures Am J Gastroenterol 101 243-7 16454825 1:CAS:528:DC%2BD28XitFSgsbY%3D 10.1111/j.1572-0241.2006.00457.x
153. T Nishizawa H Suzuki K Kurabayashi T Masaoka H Muraoka M Mori 2006 Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan Antimicrob Agents Chemother 50 1538-40 16569878 1:CAS:528:DC%2BD28XjvFOrsbg%3D 10.1128/ AAC.50.4.1538-1540.2006
154. Nishizawa T, Suzuki H, Umezawa A, Muraoka H, Iwasaki E, Masaoka T, et al. Rapid detection of point mutations conferring resistance to fluoroquinolone in gyr A of Helicobacter pylori by allele-specific polymerase chain reaction. J Clin Microbiol 2006; Nov.22; [Epub ahead of print]
155. WA de Boer GN Tytgat 1995 The best therapy for Helicobacter pylori infection: Should efficacy or side-effect profile determine our choice? Scand J Gastroenterol 30 401-7 7638563 1:STN:280:ByqA28rnsFA%3D
156. LA Fischbach S van Zanten J Dickason 2004 Meta-analysis: The efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies Aliment Pharmacol Ther 20 1071-82 15569109 1:CAS:528:DC%2BD2MXmtVantQ%3D%3D 10.1111/j.1365-2036.2004.02248.x
157. N Sakaki 2003 Problems occurring after Helicobacter pylori eradication and their countermeasures Nippon Rinsho 61 119-24 12607328
158. A Raghunath AP Hungin D Wooff S Childs 2003 Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: Systematic review BMJ 326 73712676842 10.1136/bmj.326.7392.737
159. AS Raghunath AP Hungin D Wooff S Childs 2004 Systematic review: The effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis Aliment Pharmacol Ther 20 733-44 15379833 1:STN:280:DC%2BD2cvmvFSjsw%3D%3D 10.1111/j.1365-2036.2004.02172.x
160. P Moayyedi R Feltbower J Brown S Mason J Mason J Nathan 2000 Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: A randomised controlled trial. Leeds HELP Study Group Lancet 355 1665-9 10905240 1:STN:280:DC%2BD3czmtFWktw%3D%3D 10.1016/S0140-6736(00)02236-4
161. RF Harvey JA Lane LJ Murray IM Harvey JL Donovan P Nair 2004 Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol Helicobacter project BMJ 328 141715126313 10.1136/bmj.38082.626725.EE
162. S Nomura H Esumi C Job SS Tan 1998 Lineage and clonal development of gastric glands Dev Biol 204 124-35 9851847 1:CAS:528:DyaK1cXotFSjurY%3D 10.1006/dbio.1998.9055
163. JC Mills N Andersson CV Hong TS Stappenbeck JI Gordon 2002 Molecular characterization of mouse gastric epithelial progenitor cells Proc Natl Acad Sci U S A 99 14819-24 12409607 1:CAS:528:DC%2BD38Xpt1yrtrk%3D 10.1073/pnas.192574799
164. J Mahdavi B Sonden M Hurtig FO Olfat L Forsberg N Roche 2002 Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation Science 297 573-8 12142529 1:CAS:528:DC%2BD38XlslWku7s%3D 10.1126/science.1069076
165. DG Evans TK Karjalainen DJ Evans Jr DY Graham CH Lee 1993 Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori J Bacteriol 175 674-83 7678592 1:CAS:528:DyaK3sXkvVOqsb4%3D
166. HJ Bennett IS Roberts 2005 Identification of a new sialic acid-binding protein in Helicobacter pylori FEMS Immunol Med Microbiol 44 163-9 15866211 1:CAS:528:DC%2BD2MXjslKgsLw%3D 10.1016/j.femsim.2004.11.008
167. S Bury-Mone JM Thiberge M Contreras A Maitournam A Labigne H De Reuse 2004 Responsiveness to acidity via metal ion regulators mediates virulence in the gastric pathogen Helicobacter pylori Mol Microbiol 53 623-38 15228539 1:CAS:528:DC%2BD2cXmt1agsrc%3D 10.1111/ j.1365-2958.2004.04137.x
168. JD Oh H Kling-Backhed M Giannakis LG Engstrand JI Gordon 2006 Interactions between gastric epithelial stem cells and Helicobacter pylori in the setting of chronic atrophic gastritis Curr Opin Microbiol 9 21-7 16406776 1:CAS:528:DC%2BD28XhtFSitbk%3D 10.1016/j.mib.2005.12.013
169. J Houghton C Stoicov S Nomura AB Rogers J Carlson H Li 2004 Gastric cancer originating from bone marrow-derived cells Science 306 1568-71 15567866 1:CAS:528:DC%2BD2cXhtVCisLbE 10.1126/science.1099513
170. H Suzuki BJ Marshall T Hibi 2006 Overview: Helicobacter pylori and extragastric disease Int J Hematol 84 291-300 17118754 10.1532/ IJH97.06180
171. D Veneri M Krampera M Franchini 2005 High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: A long-term follow-up study Platelets 16 117-9 15823868 1:CAS:528:DC%2BD2MXivF2isbk%3D 10.1080/09537100400015153
172. D Veneri M Franchini M Krampera G de Matteis P Solero G Pizzolo 2005 Analysis of HFE and TFR2 gene mutations in patients with acute leukemia Leuk Res 29 661-4 15863206 1:CAS:528:DC%2BD2MXjs1Klt74%3D 10.1016/ j.leukres.2005.01.001
173. T Inaba M Mizuno S Take K Suwaki T Honda K Kawai 2005 Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan Eur J Clin Invest 35 214-9 15733077 1:STN:280:DC%2BD2M7gtlGnsg%3D%3D 10.1111/j.1365-2362.2005.01471.x
174. M Konno S Muraoka M Takahashi T Imai 2000 Iron-deficiency anemia associated with Helicobacter pylori gastritis J Pediatr Gastroenterol Nutr 31 52-6 10896071 1:STN:280:DC%2BD3M7itFCmtw%3D%3D 10.1097/ 00005176-200007000-00012
175. G Baysoy D Ertem E Ademoglu E Kotiloglu S Keskin E Pehlivanoglu 2004 Gastric histopathology, iron status and iron deficiency anemia in children with Helicobacter pylori infection J Pediatr Gastroenterol Nutr 38 146-51 14734875 1:CAS:528:DC%2BD2cXlvFWgug%3D%3D 10.1097/ 00005176-200402000-00008
176. S Nahon P Lahmek J Massard B Lesgourgues N Mariaud de Serre L Traissac 2003 Helicobacter pylori-associated chronic gastritis and unexplained iron deficiency anemia: A reliable association? Helicobacter 8 573-7 14632670 10.1111/j.1523-5378.2003.00184.x
177. YH Choe SK Kim YC Hong 2003 The relationship between Helicobacter pylori infection and iron deficiency: Seroprevalence study in 937 pubescent children Arch Dis Child 88 17812538339 1:STN:280:DC%2BD3s%2FjtVGlsg%3D%3D 10.1136/adc.88.2.178-a
178. B Annibale M Marignani B Monarca G Antonelli A Marcheggiano G Martino 1999 Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis Ann Intern Med 131 668-72 10577329 1:STN:280:DyaK1Mvls1Cnuw%3D%3D
179. M Marignani S Angeletti C Bordi F Malagnino C Mancino G Delle Fave 1997 Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection Scand J Gastroenterol 32 617-22 9200297 1:STN:280:ByiA2cznslA%3D
180. M Kostaki S Fessatou T Karpathios 2003 Refractory iron-deficiency anaemia due to silent Helicobacter pylori gastritis in children Eur J Pediatr 162 177-9 12655422
181. G Russo-Mancuso F Branciforte M Licciardello M La Spina 2003 Iron deficiency anemia as the only sign of infection with Helicobacter pylori: A report of 9 pediatric cases Int J Hematol 78 429-31 14704035 1:CAS:528:DC%2BD2cXkslGmsw%3D%3D
182. A Shiotani K Okada K Yanaoka H Itoh S Nishioka M Sakurane 2001 Beneficial effect of Helicobacter pylori eradication in dermatologic diseases Helicobacter 6 60-5 11328367 1:STN:280:DC%2BD3MvjsFGrsQ%3D%3D 10.1046/j.1523-5378.2001.00009.x
183. S Fukuda T Shimoyama N Umegaki T Mikami H Nakano A Munakata 2004 Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria J Gastroenterol 39 827-30 15565400 10.1007/s00535-004-1397-7
184. DG Federman RS Kirsner JP Moriarty J Concato 2003 The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria J Am Acad Dermatol 49 861-4 14576665 10.1016/ S0190-9622(03)00846-6